Addressing adverse events through clinical indicators

Journal of quality in clinical practice Pub Date : 2002-02-28 DOI:10.1046/j.1440-1762.1999.00294.x

R Portelli BAppSc (MRA), Grad Cert (Qual Imp in Health Care), B Collopy AM, MBBS, FRCS, FRACS, FRACMA, P Desmond MBBS, FRACP

{"title":"Addressing adverse events through clinical indicators","authors":"R Portelli BAppSc (MRA), Grad Cert (Qual Imp in Health Care), B Collopy AM, MBBS, FRCS, FRACS, FRACMA, P Desmond MBBS, FRACP","doi":"10.1046/j.1440-1762.1999.00294.x","DOIUrl":null,"url":null,"abstract":"<p> <b>Abstract</b> In an attempt to improve the reporting rate of adverse drug reactions the Adverse Drug Reaction Advisory Committee approached the Australian Council on Healthcare Standards Care Evaluation Program to develop a set of indicators to improve healthcare standards by heightening awareness amongst clinical staff of the morbidity, mortality and financial implications of adverse drug reactions. Ten clinical indicators addressing: (i) reporting of adverse drug reactions; (ii) adherence to treatment protocols for anaphylaxis; (iii) monitoring of warfarin; and (iv) monitoring of streptokinase, were field tested in ten Australian health-care organizations, to determine that the data were available, that the indicators were relevant to clinical practice and that the measures were achievable. Based on the results of this field test, six adverse drug reaction clinical indicators will be introduced into the Australian Council on Healthcare Standards Evaluation and Quality Improvement Program from January 1999.</p>","PeriodicalId":79407,"journal":{"name":"Journal of quality in clinical practice","volume":"19 2","pages":"79-83"},"PeriodicalIF":0.0000,"publicationDate":"2002-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1440-1762.1999.00294.x","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of quality in clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1046/j.1440-1762.1999.00294.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

Abstract In an attempt to improve the reporting rate of adverse drug reactions the Adverse Drug Reaction Advisory Committee approached the Australian Council on Healthcare Standards Care Evaluation Program to develop a set of indicators to improve healthcare standards by heightening awareness amongst clinical staff of the morbidity, mortality and financial implications of adverse drug reactions. Ten clinical indicators addressing: (i) reporting of adverse drug reactions; (ii) adherence to treatment protocols for anaphylaxis; (iii) monitoring of warfarin; and (iv) monitoring of streptokinase, were field tested in ten Australian health-care organizations, to determine that the data were available, that the indicators were relevant to clinical practice and that the measures were achievable. Based on the results of this field test, six adverse drug reaction clinical indicators will be introduced into the Australian Council on Healthcare Standards Evaluation and Quality Improvement Program from January 1999.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

通过临床指标处理不良事件

为了提高药物不良反应的报告率，药物不良反应咨询委员会与澳大利亚医疗保健标准护理评估计划委员会合作，制定了一套指标，通过提高临床工作人员对药物不良反应的发病率、死亡率和财务影响的认识来提高医疗保健标准。十个临床指标涉及:(i)报告药物不良反应;(ii)遵守过敏反应治疗方案;(iii)华法林监测;(四)链激酶监测，在十个澳大利亚保健组织进行了实地测试，以确定数据可用，指标与临床实践相关，措施是可以实现的。根据这一实地试验的结果，从1999年1月起，澳大利亚保健标准评估和质量改进方案理事会将引入6项药物不良反应临床指标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助